Drug balloon as well as preparation method and application thereof
A balloon and drug technology, applied in the direction of balloon-shaped catheters, catheters, etc., can solve problems such as poor firmness, uneven drug distribution, drug coating wash-off, etc., to achieve enhanced bioavailability, firm drug coating, The effect that is not easy to wash off
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0053] like figure 1 Shown is a preparation method of a drug balloon of the present invention, the preparation method of the present invention includes: mixing the active drug and the carrier to form a mixed solution; spraying the mixed solution onto the surface of the balloon, and treating the solvent of the mixed solution evaporate to dryness to obtain the balloon with drug coating on the surface.
[0054] A preferred embodiment of the preparation method of the drug balloon of the present invention specifically includes the following steps:
[0055] Step 1, mixing the active drug and the carrier to form a mixed solution;
[0056] Step 2. Spray the mixed solution prepared in step 1 onto the surface of the balloon, and wait for the solvent to evaporate to dryness to obtain a balloon with a drug coating on the surface;
[0057] Step 3: Solve the surface of the drug-coated balloon prepared in step 2, and then perform split-folding to obtain a drug balloon.
[0058] In step 1,...
Embodiment 1
[0079] In this example, drug balloons were prepared by the following method:
[0080] Step 1, 30% active drug (rapamycin and its derivatives or paclitaxel) and 30% polyethylene glycol, 5% polyethylene glycol-polylactic glycolic acid, 35% phospholipids are fully dissolved in dichloromethane form a mixed solution;
[0081] Step 2. Spray the mixed solution of the active drug prepared in step 1 and polyethylene glycol, polyethylene glycol-polylactic-glycolic acid, and phospholipids directly onto the surface of the balloon. The drug solution contains the active drug rapamycin and its The solution of derivatives or paclitaxel and carrier mannitol, the drug concentration in the drug solution is 30mg / mL, in order to accurately control the amount of the drug solution sprayed onto the balloon, use a precision injector and a sprayer to spray to obtain a uniform Drug coating, by controlling the process parameters to achieve the expected drug dosage, after the spraying is completed, a bal...
Embodiment 2
[0084] In this example, drug balloons were prepared by the following method:
[0085] Step 1, 30% of active drug (rapamycin and its derivatives or paclitaxel) and PLGA material are prepared into 1-5 μm particles and 30% polyethylene glycol, 5% polyethylene glycol-polylactic acid by spray drying Glycolic acid and 35% phospholipids are fully dissolved in ethanol solution to form a suspension;
[0086] Step 2, the suspension prepared in step 1 is directly sprayed on the surface of the balloon, the drug suspension is a solution containing active drug rapamycin and its derivatives or paclitaxel PLGA particles and carrier, the drug PLGA particles are mixed The drug concentration in the suspension is 30mg / mL. In order to accurately control the amount of the drug solution sprayed onto the balloon, a precision injector and a sprayer are used for spraying to obtain a uniform drug coating. By controlling the process parameters to achieve the desired After the spraying is completed, a ba...
PUM
Property | Measurement | Unit |
---|---|---|
concentration | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com